Abstract
Keywords
Medication error Prescription error Outpatient Prescription Faculty physicians Non-faculty physicians
Introduction
“A prescription drug order is a lawful written instruction from a licensed physician or other medical practitioner to a licensed pharmacist regarding the compounding or dispensing and administration of drug/s or other medical services to the patient” (1). Prescriptions are intended to improve patients’ quality of life by curing a disease, reducing or eliminating the symptoms, slowing or arresting disease process, or preventing a disease or its symptoms from appearing in the first place (2). Rational prescribing is based on a sound knowledge as it requires understanding the pathophysiology of the diseases as well as clinical pharmacology of the drugs used (3). The purpose is to achieve maximum benefits while respecting the patient’s choice and minimizing costs and risks (4). Irrational drug prescribing has been identified as one of the risk factors for medication error (ME) (5). A ME is defined as “a failure in the treatment process that leads to, or has the potential to lead to, or harm the patient.” (6).Medication Errors (MEs) compromise patient confidence in the healthcare system and can increase healthcare costs (7). According to the reports of the Institute of Medicine 44,000 to 98,000 Americans die each year due to (MEs) (8) and the annual cost is 77 billion dollars (9). It has been predicted that the rate of serious MEs in the USA is approximately 7% (10). The frequency of (MEs) was reported and analyzed in different parts of healthy stages in Iran (11-13).
Potentially errors can occur at any steps in the medication process including prescribing, transcribing, dispensing, administering and monitoring (14). The prescribing stage is mostly prone to errors, accounting for 49% of MEs (14). Prescription error is defined as “any preventable event that may cause or lead to inappropriate medication or patient harm when the medication is in the control of the health care professional, patient or consumer” (15). Several causes have been reported for occurrence of prescription errors, such as lack of knowledge and illegible physicians' handwritings (16). The components of a prescription should be clearly written, free of omission and commission errors (1, 16). Identifying of medication errors in outpatient prescriptions is difficult and there are few data available about the frequency and impact of these errors (17). One study has shown that 15-21% of outpatient prescriptions contain at least one error (17). In another study by Buurma et al. (18) 16% of patients reported a ME and two-thirds of cases were in outpatient settings. One study (19) has reported that MEs can occur at any age however it has a higher rate of occurrence in pediatrics and elderly patients compared to adults.
The aim of this study is to identify common types of handwritten MEs in outpatient prescriptions and compare the rate of MEs between physicians who are faculty members affiliated to Shiraz University of Medical Sciences (SUMS) and those physicians practicing in Shiraz who are not affiliated to the university (non-faculty).
Experimental
Data collection
This study was a cross-sectional survey of 2000 outpatient prescriptions received at educational pharmacies affiliated with SUMS and health insurance companies in Shiraz, Iran. Shiraz is the capital of Fars province in Iran. These prescriptions were selected randomly from March to September 2012, regardless of sex, race and age. Ethics committee of SUMS approved this study and information related to patients and physicians remained confidential.
Prescriptions were categorized into two groups: faculty and non-faculty according to the physicians’ stamps. Prescriptions were analyzed based on gender of physician and patient, age of patient, academic position in case of faculty physicians (assistant professor , associate professor, or full professor), physicianꞌs level of training (general practitioner, specialist or fellowship) , field of practice and number of generic and brand drugs per prescription.
The commission and omission errors were determined in this study as: number of messy and illegible spelling of drugꞌs name, number of dosage form errors, strength errors, instruction errors (dosage, route, frequency and duration), quantity errors, drug-drug interactions, contraindications and combination errors. We also determined if the chief complain and diagnosis was mentioned in the footnote of prescription or not. According to the regulation of prescribing in Iran. Physicians should write the chief complain and diagnosis on the prescription. In the current article commission and omission errors are presented in a single output. In this investigation “Instruction errors” indicates the wrong dosage regimen prescribed for a specific disease. In order to calculate the approximate range of dosages for pediatrics, the weight-age Table was used because Iranian physicians usually do not include weight of patients on prescriptions. If the prescribed dosage did not match the standard dosage, it was considered as erroneous. Contraindications based on appropriateness of a drug for a specific age or sex, as there was the only information available. Combination errors were determined using the prescribed drugꞌs strength, dosage form, quantity, and instruction regimen for the specific disease in each prescription by protocols defined in references (20, 21). In addition, prescribing drugs in the same pharmacology class (duplicate drugs) were considered as combination errors.
Spelling, dosage form and strength were determined by drug information handbook of Lexi® (22) and Iranpharma (the pharmacopeia of Iran) (23). Other prescription errors were identified based on Medscape® (24) database software and drug information handbook of Lexi® (22) and Lexi-Comp drug-drug interactions software version 1.9.1 (25) alongside clinical judgment of clinical pharmacist.
An experienced pharmacist reviewed prescriptions to identify and categorize likely prescription errors. All prescriptions with suspected prescription errors were double checked and evaluated by two clinical pharmacists affiliated to SUMS to confirm the errors.
Statistical Analysis
Data analysis was performed using Statistical Package for Social Sciences (SPSS version 20 “IBM© SPSS Statistic) software. Continuous data is presented as mean ± SD and categorical data is shown as frequency or percent. The relationships between number of drugs per prescription, patient and physician characteristics and rate of occurrence of prescription errors were examined. The differences between the mean ± SD of two continuous data groups were examined with t-test. ANOVA was used to determine the difference between means of more than two continuous variable groups. Post-hoc analysis was examined where ANOVA-test was significant. Chi-square test was processed to determine the difference between categorical data. P-value less than 0.05 were considered as significant difference.
For further evaluation prescriptions were categorized into 3 groups based on the number of prescribed drugs: 1-2, 3-4, and ≥ 5 drugs in each prescription. In each group, the ratio of total errors per number of prescribed drugs was calculated.
Results
Total of 2000 prescriptions were collected randomly during six months.1000 prescriptions were written by faculty members and 1000 prescriptions by non-faculty. Table 1 shows the characteristics of physicians.
By studying the field of specialty of physicians, it was found that the majority (9.50%) of physicians were neurologists and minority (0.30%) were anesthesiologists. In addition, the least number of faculty members were anesthesiologists while for non-faculty members infectious disease specialists were the minority group. Most female physicians were gastroenterologists while most male physicians were neurologists.
In this study only 1 out of 2000 prescriptions contained chief complain and 21 of them contained diagnosis (faculty member, 1.8% vs. non-faculty, 0.30%, p > 0.05).
The mean ± SD age of patients was 37.91 ± 21.10 years. The differences between age of males and females were not significant (P-value = 0.26). Most of the patients (N = 1509, 81.5 %) were adults. The mean ± SD prescription errors was 7.38 ± 4.06 (N = 14764) (excluding chief complain and diagnosis). The minimum and maximum errors observed in one prescription were 1 and 26 errors, respectively. Femalesꞌ prescription had significantly higher errors than malesꞌ prescriptions (7.63 ± 4.17 vs. 7.04 ± 3.90, P = 0.00).
Prescription errors are shown in Table 2
The highest rate of prescription errors (49.02%) were observed in psychiatrists. The rate of occurrence of prescription errors were higher in adult patients than pediatrics; however this difference was not significant (7.46 ± 4.07 vs. 7.07 ± 4.11, P-value = 0.11). One thousand and ninety drugs were prescribed by trade names. The mean ± SE of trade names were (0.55 ± 0.017). Faculty physicians used trade name less frequently than non-faculty members, significantly (0.48 ± 0.021 vs. 0.61 ± 0.027, P = 0.00).
As mentioned in the statistical analysis, the ratio of errors to total number of drugs in each prescription was calculated. Errors are shown in the Table 3. The difference between prescription errors based on total number of drugs prescribed was significant. The mean of errors in all groups of prescription errors increased significantly as number of prescribed drugs increased.
In the faculty member group academic grade did not have a significant effect on rate of occurrence of ME (P > 0.05).
Discussion
Our study has demonstrated a wide range of prescription errors associated with 2000 prescriptions from faculty and non-faculty physicians in Shiraz, Iran. We documented 14764 errors from 2000 prescriptions. All prescriptions (100%) had at least one error. The maximum prescription error was 26 errors in one prescription. The total MEs in our study were greater than previous studies in Iran. In a study by Vazin et al. 68.5% of prescription had an error (12), Abbasinazari et al. (11) detected 262 errors in 132 patients (1.98 per each patients) and in Malaysia Kuan Mon Ni et al. (26) only 13 out of the 397 prescriptions screened complied with all the legal requirements. T. Khoja et al. (27) found that 18.7% of their prescriptions (5299) contained an error. Perwitasari et al. (28) reported 98.69% error in their study which was similar to our result. This indicates a need for the physicians to further emphasize the necessity of writing prescriptions clearly, and completely. Several causes of the high rate of prescription errors in our study compared to other studies were handwritten prescriptions, difference in references used for identify prescription errors and different populations studied.
The mean ± SD errors in prescriptions written by faculty members was significantly lower than the non-faculty members (6.93 ± 3.88 Vs 7.83 ± 4.2, P-value < 0.001). Faculty members practice in the academic area and have more complicated patients daily. They have the responsibility to educate the medical students and therefore need to keep themselves up to date.
The mean number of drugs prescribed per prescription in our study was 3.21 ± 1.71. This was similar to previous reports (3.0-4.5) from Nigeria (29, 30) and higher than a study in Urmia (31). (N = 2.54 ± 0.58; 2.26 ± 0.43 for faculty vs. 2.65 ± 0.59 for non-faculty, P-value < 0.001). This finding may be related to the greater awareness of faculty members about the existence of Rational Use of Drugs (RUD) committee in the university as an official authority for evaluation of physicians (31). Based on the latest available annual repoort of Iranian RUD committee in 2011, the mean number of drugs per prescription for all prescriber in Iran was 3.05 (31). Developing countries with programs promoting rational drug use as well as standards have described lower drug prescription errors rates, such as primary health care center in Jordan (2.3%), primary health care center in Tanzania (2.9%) and private hospitals in Uzbekistan (2.9%) (32, 33). Poly pharmacy has been reported as one of the causes of prescription errors (such as increasing drug-drug interactions and combination error), increasing costs for patients and confusing patients (34).
In our study average patientsꞌ age was 37.91 ± 21.10 years. About 7.45% of our prescriptions didnꞌt have any information about age or date of birth. In our study, we had a lower rate of lack of patient’s age data compared to a research conducted at Government Hospitalian Yogyakarta Indonesia in 2010 (52.4% of 229) registered outpatients (28). One study in Oman reported that patientꞌs age is one of the most common omission errors and itꞌs frequency of occurrence was more than 72% (35). The age has a great impact on the prescription and it is a very important variable in terms of dose and dosage form. The omission of age in prescriptions could be a reflection of the fact that some physicians does not appreciate the legal status of a prescription order (28).
The mean ± SD spelling error was 1.95 ± 0.03 (11% in 2000 prescriptions) in our study which is higher than research done by Kuan Mun Ni et al. (26) who screened the prescriptions and were unable to read about 7% of prescriptions in their sample. In this study, 6.11% in 229 prescriptions contained spelling errors.
In our study, the mean ± SD strength error was 1.42 ± 0.03 (9.20% in 2000 prescriptions) and dosage form errors were 0.68 ± 0.02 (4.85% in 2000 prescriptions). Kuan Mon Ni et alꞌs study (26) 56.26% (485/862) of drugs were prescribed without strength specifications. Our study indicated lower errors than the mentioned study in Indonesia. Kuan Mon Ni et al. (26) reported that among 391 studied prescriptions, 27out of 862 drugs had wrong written dosage forms and 314 out of 862 drugs didn’t have dosage forms.
The characteristics of study physicians (N = 2000).
Characteristics of physicians | Faculty prescription | Non-faculty prescription | Total prescription | |
---|---|---|---|---|
Sex | Male | 840 (84%) | 703 (70.3%) | 1543 (77.15%) |
Female | 160 (16%) | 297 (29.7%) | 457 (22.85%) | |
Field of | General-physician | - | 292 (29.2%) | 292 (14.6%) |
Specialist | 446 (44.6%) | 534 (53.4%) | 980 (49%) | |
Fellowship | 554 (55.4%) | 174 (17.4%) | 728 (36.4%) | |
Academicals | Associate professor | 461 (46.1%) | - | 461 (23.05%) |
Assistant professor | 360 (36%) | - | 360 (18%) | |
Full-professor | 179 (17.9%) | - | 179 (8.95%) |
Total number of errors extracted from outpatients' prescriptions (Number of prescription = 2000).
Errors | Faculty prescriptions | Non-faculty prescriptions | Total prescriptions (N = 2000) | P-value |
---|---|---|---|---|
Total numbers of prescribed drugs mean ± SD(N) | 3.02 ± 1.72 | 3.39 ± 1.69 | 3.21 ± 1.71 | 0.00 |
Spelling error mean ± SD(N) | 1.66 ± 0.04 | 2.24 ± 0.04 | 1.95 ± 0.03 | 0.00 |
Instruction error mean ± SD(N) | 1.44 ± 0.04 | 1.66 ± 0.03 | 1.55 ± 0.03 | 0.00 |
Strength error mean ± SD(N) | 1.21 ± 0.03 | 1.62 ± 0.045 | 1.42 ± 0.03 | 0.00 |
Dosage error mean ± SD(N) | 0.80 ± 0.04 | 0.56 ± 0.031 | 0.68 ± 0.02 | 0.00 |
Quantity error mean ± SD(N) | 0.47 ± 0.02 | 0.43 ± 0.026 | 0.45 ± 0.01 | 0.22 |
Combination error | 0.21 ± 0.01 | 0.22 ± 0.01 | 0.22 ± 0.00 | 0.356 |
Contraindication mean ± SD(N) | 0.03 ± 0.00 | 0.02 ± 0.00 | 0.03 ± 0.00 | 0.02 |
Drug-drug interaction mean ± SD(N) | 0.12 ± 0.01 | 0.08 ± 0.01 | 0.1 ± 0.00 | 0.00 |
Total prescription errors mean ± SD(N) | 6.93 ± 3.88 | 7.83 ± 4.2 | 7.38 ± 4.06 | 0.00 |
Total prescription errors based on total numbers of drugs prescribed.
Total numbers of drugs per prescription | The Mean ± SD prescription errors based on total numbers of drugs per prescription | |||||
---|---|---|---|---|---|---|
Spelling error | Dosage form error | Strength error | Instruction error | Quantity error | Total errors | |
1-2 | 1.39 ± 0.49 | 0.39 ± 0.02 | 0.72 ± 0.03 | 0.86 ± 0.03 | 0.22 ± 0.01 | 2444 |
3-4 | 2.35 ± 0.93 | 0.67 ± 0.03 | 1.70 ± 0.04 | 1.65 ± 0.03 | 0.52 ± 0.02 | 6202 |
≥5 | 3.66 ± 1.56 | 1.41 ± 0.11 | 2.4 ± 0.09 | 2.91 ± 0.10 | 0.75 ± 0.06 | 4139 |
P-value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
Amount of omission and commission errors were 39.55 % (26). If the strength of a drug is incorrect, it may lead to more serious consequences compared to when the strength is not written at all. If the drug is only available in a fixed dosage form, this type of error could be easily identified and rectified. An incorrect dosage form does not lead to serious consequences unless the strength or the frequency of use of that dosage form is also incorrect (26).
In our survey, the mean ± SD instruction error was 1.55 ± 0.03 (10.64% in 2000 prescriptions), which is lower than the results of previous studies by Nadiya et al. (35) and Perwitasari et al. (28) who reported the instruction errors to be 46.33% and 26.43%, respectively. Based on a survey conducted in a general practice in USA, the highest frequency of errors was due to incomplete or missing instruction (36). Instructions should be clear, complete and should provide careful instructions for pharmacists about the patient’s situation (35).
Our results showed that pediatric patients had 2421 (17.69%) errors in 2000 prescriptions. Pediatrics pose a unique set of risks of prescription errors, predominantly because of the need to make dosage calculations, which are individually based on patientꞌs weight. Therefore, lack of patientꞌs weight, may result in overdose or under dose and patients would not benefit from treatment (37, 38). Lack of appropriate information such as patientꞌs weight makes it difficult for pharmacists to carry out a prescription (37). In our study, none of the prescriptions stated patient’s weight. It is possible that the physicians consider the patientꞌs weight (especially pediatrics) before prescribing and calculate the dose, therefore this may not lead to an error. In the study by Perwitasari et al., Only 3 prescriptions included patient’s weight and 98.69% of the prescriptions lacked this variable (28).
The mean ± SD quantity errors were 0.45 ± 0.01 (4.17% in 2000 prescriptions). In a study by Kuan Mun Ni et al. (26), they reported that 50 out of 862 (5.8%) drugs had quantity errors. Prescriptions should state the quantity of each drug. Although some drugs may be given on “as required” basis, the physician is still the best judge on the total quantity to be supplied based on the patient medical requirement. Even for dermatological, eye, ear, and nasal preparations, documentation of the amount to be supplied is still necessary (26). In this study, quantity was considered as an indicator for treatment duration. If the quantity of drug/drugs is not enough the duration of treatment would not be completed which can increase the probable risk of treatment failure. On the other hand, excess amount of drugs may cause adverse effects, increase patient’s cost and drug waste (34).
Combination therapy is considered to increase the efficacy of drug therapy. However, if co-prescribed drugs have the same mechanism of action or they antagonize each other, a combination error is observed. In our study, 433 (2.93%) in 2000 prescriptions had combination errors. We could not find any published study about these types of errors.
In the present study 52 (2.60%) in 2000 prescriptions had contraindication error. Our rate was higher than the reported rates by Teixeira et al. in Brazil (0.4% of the prescriptions contained contraindications) (39) and Guedon et al. in France (0.4% contraindication in outpatient prescriptions) (40). Describing “chief complain” and “diagnosis” help us identify contraindication but our physicians did not include these data. Thus we reported contraindication error only based on sex and age of patients. Therefore, our findings may be underestimated.
In this study 1090 (40.7%) drugs were prescribed by trade names. The rate of drugs prescribed by trade names was lower than rate of using generic names (7-7.3%) in other studies (30, 33). Generic prescribing makes is possible to dispense various brands of drugs that are cheaper than or are as effective as proprietary brands (4). The several suggestions for this type of prescription error in our study are as follows: 1-physicians are not certain enough about quality of generic drugs. 2-Trade names are used because physicians are more familiar with trade names than generic names. 3-when some drugs are launched in Iranꞌs market for the first time, they often are introduced by their trade names and prescribing drugs using trade name has become a routine.
Overall, the rate of occurrence of prescription errors in this study was higher than others (26-28). Some reasons for this difference may be: 1) Differences in prescribing systems between our country and other countries; 2) Use of different references to identify errors, 3) differences in sample size and design of studies such as different ways of selecting prescriptions.
Our study had some limitations: 1) Prescriptions were limited to handwritten prescriptions. Verbal instructions of physicians to patients remain unknown. 2) This study covered Shiraz city. Since certain types of drugs are available in a specific city, it’s possible that our study is restricted to certain types of drugs. Our results canꞌt be generalized to another university of Iran. For example in some therapeutic centers in Iran, the prescription control committee can be very strict making physicians to write prescriptions more carefully. 3) Our study’s focus was mainly on prescription errors and was not designed to detect adverse drug events or other complications of medication errors. 4) Vast majority of physicians did not state chief complain and diagnosis on their prescriptions, therefore it was not possible to make accurate judgments on all prescriptions especially regarding combination and contraindication errors. 5) One of the reasons for diversity in our results may be due to the fact that various types of physicians were included in our study. Prescriptions were selected using random sampling and there was no criteria or limits on the number of physicians in this study. 6) Because our study was retrospective, some contraindication errors, combination errors and quantity errors may not have a true error.
Acknowledgements
References
-
1.
Ansari M, Neupane D. Study on determination of errors in prescription writing: A semi-electronic perspective. Kathmandu. Univ. Med. J. 2009;7:238-41.
-
2.
Oyedunni S, Simon K, Oluwole M. Prescription errors prevalent in four units of univarsity teaching hospital in Nigeria. J. Public. Health. Epidemiol. 2011;3:513-9.
-
3.
Grahame-Smith D G, Aronson J K. Principles of prescribing and how to write prescriptions. 3nd ed. New York: Oxford University Press; 2002.
-
4.
Oshikoya K A, Chukwura HA, Ojo O I. Evaluation of outpatient paediatric drug prescriptions in a teaching hospital in Nigeria for rational prescribing. Paediatr. Perinat. Drug Ther. 2006;7:183-8.
-
5.
Olayemi SO, Akinyede AA, Oreagba AI. Prescription pattern at primary health care centres in Lagos State. Niger. Postgrad. Med. J. 2006;13:220-4. [PubMed ID: 17066110].
-
6.
Aronson JK. Medication errors: what they are, how they happen, and how to avoid them. QJM. 2009;102:513-21. [PubMed ID: 19458202].
-
7.
ASHP statment on reporting medication errors. J. Am. Med. Assoc. 2007;50:151.
-
8.
Pankaj Agrawal AS RKS, Pankaj Jaina. Statistical Analysis of Medication Errors in Delhi, India. Indo. Global. J. Pharm. Sci. 2012;2:88-97.
-
9.
Grissinger MC, Globus NJ, Fricker MP Jr. The role of managed care pharmacy in reducing medication errors. J. M. C. P. 2003;9:62-5.
-
10.
Michel P, Quenon JL, de Sarasqueta AM, Scemama O. Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. B. M. J. 2004;324:199.
-
11.
Abbasinazari M, Eshraghi A, Sahraei Z. Detection and management of medication errors in internal wards of a teaching hospital by clinical pharmacists. Acta. Med. Iran. 2013;51:482-6. [PubMed ID: 23945894].
-
12.
Afsaneh Vazin, Zamani Z, Nahid Hatam. Frequency of medication errors in an emergency department of a large teaching hospital in southern Iran. Drug. Healthc. Patient. Saf. 2014;11:179-84.
-
13.
Snor Bayazidi YZ, Vahid Zamanzadeh, Kobra Parvan. Medication Error Reporting Rate and its Barriers and Facilitators among Nurses. J. Caring. Sci. 2012;1:231-6. [PubMed ID: 25276700].
-
14.
Bates DW. A 40 year old woman who noticed a medication error. J. A. M. A. 2001;285:3134-40.
-
15.
Rockville Maryland. The standard United States pharmacopoeia. United States; 1995.
-
16.
Minakshi Marwaha, Rakesh Kumar Marwaha, Jyoti Wadhwa Padi S. A retrospective analysis on a survey of handwritten prescription errors in general practice. Int. J. Pharm. Pharm.Sci. 2010;3:80-2.
-
17.
Tejal K, Gandhi M M, Saul N Weingart, Andrew C Seger, Joshua Borus B, Elisabeth Burdick MS, Eric G Poon, Lucian L Leape, David W, Bates M. Outpatient Prescribing Errors and the Impact of Computerized Prescribing. J. G. I. M. 2003;20:837-41.
-
18.
Buurma H dsp, Van den Hoff OP, Egberts AC. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br. J. Clin. Pharmacol. 2001;52:85-91. [PubMed ID: 11453894].
-
19.
Levine CM. Preventing medication errors in pediatric and neonatal patients. 2nd ed. Washington: American Pharmacists Association; 2007.
-
20.
Koda-Kimble MA. Applied Therapeutics. 11th ed. Baltimore: Wolters Kluwer / Lippincott Williams & Wilkins; 2013.
-
21.
Joseph T, DiPiro RLT GCY. Pharmacotherapy, A Pathophysiologic Approach. 8th ed. 2011.
-
22.
Drug information Handbook of lexi with International Trade Names Index. 21st ed. USA: Lexi- Comp; 2009.
-
23.
Hajirahimkhan S K Fea. A comprehensive hand book of drug information. 3rd ed. Tehran: Teimorzadeh tabib; 1387.
-
24.
Lundberg GD. Continues publication of MedGenMed beginning Medscape. J. Med. 2008;10:1.
-
25.
-
26.
Ni KM, Siang CS, bin Ramli MN. Noncompliance with prescription writing requirements and prescribing errors in an outpatient department. Malays. J. Pham. 2002;1:45-50.
-
27.
Khoja T, Neyaz Y, Qureshi NA, Magzoub MA, Haycox A and Walley T. Medication errors in primary care in Riyadh city, Saudi Arabia. East. Mediterr. Health. J. 2011;17:132-9. [PubMed ID: 21735948].
-
28.
Dyah Aryani P, Jami’ul Abror, Iis Wahyuningsih. Medication errors in outpatients of a government hospital in Yogyakarta Indonesia. Int. J. Pharm. Sci. Rev. Res. 2010;1:8-10.
-
29.
Odusanya O. The role of adjunct therapies in the treatment of uncomplicated malaria. Niger. J. Clin. Pract. 2002;5:32-6.
-
30.
Nwolisa CE, Erinaugha EU, Ofoleta SI. Prescribing practices of doctors attending to under fi ves in a children’s outpatient clinic in Owerr. Niger. J. Trop. Pediatr. 2005;52:197-200.
-
31.
Laya Sadighi-Rad LM, Mehrnush Javaezi, Mohammad Delirrad. Comparison of prescribing indicators of academic versus non-academic specialist physicians in Urmia, Iran. J. Res. Pharm. Pract. 2015;4:45-50. [PubMed ID: 25984540].
-
32.
Nsimba SE, Massele AY, Makonomalonja J. Assessing. prescribing practice in church-owned primary healthcare (PHC) institutions in Tanzania: A pilot study. Trop. Doct. 2004;34:236-8. [PubMed ID: 15510956].
-
33.
Pavin M, Nurgozhin T, Hafner G, Yusufy F and Laing R. Prescribing practices of rural primary health-care physicians in Uzbekistan. Trop. Med. Int. Health. 2003;8:182-90. [PubMed ID: 12581446].
-
34.
Pradhan SC SD, Tekur U, Zutshi S, Pachiappan D, Dey AK. Changing pattern of antimicrobial utilization in an Indian teaching hospital. Int. J. Clin. Pharmacol.Ther. Toxicol. 1990;28:339-43. [PubMed ID: 2272715].
-
35.
Al Shahaibi NM, Al Said LS, Kini T and Chitme H. Identifying errors in handwritten outpatient prescriptions in Oman. J. Young. Pharm. 2014;4:267-72.
-
36.
Chumney EC, Robinson LC. The Effect of Pharmacist Interventions on Patients with Polypharmacy. Pharm. Pract. 2006;4:103-9.
-
37.
Abdullah DC, Ibrahim NS, Ibrahim MIM. Medication errors among geriatrics at the outpatient pharmacy in a teaching hospital in Kelantan. Malays. J. Med. Sci. 2004;11:52-8.
-
38.
Wong IC GM, Franklin BD, Barber N. Incidence and nature of dosing errors in paediatric medications, a systematic review. Drug. Saf. 2004;27:661-70. [PubMed ID: 15230647].
-
39.
Teixeira JJ, Crozatti MT, dos Santos CA, Romano-Lieber NS. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil. PloS. ONE. 2012;7:e47062. [PubMed ID: 23071711].
-
40.
Guedon-Moreau L, Ducrocq D, Duc MF, Quieureux Y, L›Hote C, Deligne J, Caron J. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur. J. Clin. Pharmacol. 2003;59:689-95. [PubMed ID: 14557905].